Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)
US6685934B1 · kind B1 · utility
6Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 1996 |
| Grant date | Feb 3, 2004 |
| Priority date | — |
| Expiry date | Oct 9, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10343
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant adenoviruses comprising a heterologous DNA sequence coding for basic blast growth factors (bFGF), preparation and uses thereof for the treatment and/or prevention of neurodegenerative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.